Version history

{
  "description": "The field still under-models how sex, ancestry, infection history, and environment reshape the trajectory of immune-memory aging. Boundary domains: population-immunology, longitudinal-cohorts. Representative papers: Sex and gender differences in cognitive resilience to aging and Alzheimer's disease.; Sex hormone signaling and regulation of immune function.; Sex, Gender, and COPD.",
  "domain": "immunology-aging-memory",
  "status": "open",
  "priority_score": 0.855,
  "importance_score": 0.86,
  "tractability_score": 0.8,
  "novelty_score": 0.91,
  "composite_score": 0.855,
  "source": "landscape_analysis:landscape-immunology-aging-memory-v1",
  "evidence_summary": "Sex, ancestry, infection history, and environmental exposures profoundly shape immune-memory aging trajectories, yet population-level models remain limited. Studies tracking cytomegalovirus seropositivity, CD8+ T cell memory inflation, and antibody repertoire shifts across aging cohorts have revealed that males and females differ substantially in their rates of immunosenescence—females generally maintaining higher antibody titers and innate immune signaling but exhibiting greater autoimmune susceptibility. Genome-wide association studies of immune phenotypes in aging cohorts demonstrate that genetic ancestry accounts for substantial variance in immune-memory composition that population-averaged analyses miss (GWAS for Alzheimer's and immune traits, Nature Genetics 2022; Genome-wide meta-analysis of depression and immune traits, Nature Genetics 2019).\n\nThe core gap is that most immunosenescence studies use small, predominantly European, single-sex cohorts with limited exposure-history metadata. Infection history—particularly latent herpesvirus burden (CMV, EBV)—dramatically remodels memory compartments, yet is rarely stratified by ancestry or sex simultaneously. A longitudinal cohort study of long COVID (EClinicalMedicine 2021) illustrated how heterogeneous immune-memory trajectories are across demographics even after a single infectious exposure. Without high-dimensional, multi-strata longitudinal datasets integrating sex, ancestry, pathogen exposure history, and environmental variables, it is impossible to distinguish biological aging from accumulated exposure effects or to design population-appropriate vaccines and immunotherapies.\n\nRecent progress includes multi-omics immunological aging clocks and large-scale cohort efforts (UK Biobank, TOPMed) that capture immune phenotypes across ethnically diverse donors. Single-cell transcriptomic atlases of PBMCs from diverse aging populations are emerging. However, mechanistic understanding of how sex hormones, HLA haplotypes, and pathogen exposure interact to determine the trajectory of memory T cell and B cell aging remains fragmentary. Targeted interventions—whether boosting waning vaccine responses or dampening inflammaging—await better population-stratified models that can distinguish universal from ancestry-specific aging patterns.",
  "resolution_criteria": "Resolution requires: (1) Longitudinal immune-memory profiling (>10-year follow-up, n>=500) stratified by sex, ancestry (>=4 groups), infection history (CMV/EBV serostatus), and environmental exposures, with multivariate models attributing >=20% of immune-aging trajectory variance to each significant modifier using LME or causal forest analysis; (2) Sex-stratified vaccine response studies (n>=200 per sex) or controlled CMV-exposure cohorts showing >=1.5-fold difference in memory T/B cell attrition rates between male and female participants independent of age, confirming sex as an autonomous predictor; (3) Ancestry-specific epigenetic aging analysis (EPIC array) showing >=3 CpG sites in immune genes differentially methylated across ancestries (FDR<0.05) with functional validation in primary T cells (gene expression or protein output). Unstratified bulk immune phenotyping without interaction analyses is insufficient.",
  "market_price": 0.5
}